113 related articles for article (PubMed ID: 16678155)
1. Effects of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on vasopressin-induced growth responses in human mesangial cells.
Tahara A; Tsukada J; Tomura Y; Momose K; Suzuki T; Yatsu T; Shibasaki M
Eur J Pharmacol; 2006 May; 538(1-3):32-8. PubMed ID: 16678155
[TBL] [Abstract][Full Text] [Related]
2. Effect of YM218, a nonpeptide vasopressin V(1A) receptor-selective antagonist, on rat mesangial cell hyperplasia and hypertrophy.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Vascul Pharmacol; 2007 Jun; 46(6):463-9. PubMed ID: 17395547
[TBL] [Abstract][Full Text] [Related]
3. Binding and signal transduction characteristics of the nonpeptide vasopressin V1A receptor-selective antagonist YM218 in cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Kusayama T; Momose K; Taniguchi N; Suzuki T; Yatsu T; Shibasaki M
Pharmacology; 2006; 78(2):81-90. PubMed ID: 16966841
[TBL] [Abstract][Full Text] [Related]
4. Vasopressin stimulates the production of extracellular matrix by cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2008 May; 35(5-6):586-93. PubMed ID: 18177476
[TBL] [Abstract][Full Text] [Related]
5. Effect of vasopressin on type IV collagen production in human mesangial cells.
Tahara A; Tsukada J; Tomura Y; Suzuki T; Yatsu T; Shibasaki M
Regul Pept; 2008 Apr; 147(1-3):60-6. PubMed ID: 18258315
[TBL] [Abstract][Full Text] [Related]
6. Effects of YM218, a nonpeptide vasopressin V1A receptor-selective antagonist, on human vasopressin and oxytocin receptors.
Tahara A; Tsukada J; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M
Pharmacol Res; 2005 Mar; 51(3):275-81. PubMed ID: 15661579
[TBL] [Abstract][Full Text] [Related]
7. Effects of YM471, a nonpeptide AVP V(1A) and V(2) receptor antagonist, on human AVP receptor subtypes expressed in CHO cells and oxytocin receptors in human uterine smooth muscle cells.
Tsukada J; Tahara A; Tomura Y; Wada Ki ; Kusayama T; Ishii N; Yatsu T; Uchida W; Taniguchi N; Tanaka A
Br J Pharmacol; 2001 Jul; 133(5):746-54. PubMed ID: 11429400
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a novel nonpeptide vasopressin V(2)-agonist, OPC-51803, in cells transfected human vasopressin receptor subtypes.
Nakamura S; Yamamura Y; Itoh S; Hirano T; Tsujimae K; Aoyama M; Kondo K; Ogawa H; Shinohara T; Kan K; Tanada Y; Teramoto S; Sumida T; Nakayama S; Sekiguchi K; Kambe T; Tsujimoto G; Mori T; Tominaga M
Br J Pharmacol; 2000 Apr; 129(8):1700-6. PubMed ID: 10780976
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic properties of YM218, a novel, potent, nonpeptide vasopressin V1A receptor-selective antagonist.
Tsukada J; Tahara A; Tomura Y; Kusayama T; Wada K; Ishii N; Taniguchi N; Suzuki T; Yatsu T; Uchida W; Shibasaki M
Vascul Pharmacol; 2005 Jan; 42(2):47-55. PubMed ID: 15722249
[TBL] [Abstract][Full Text] [Related]
10. Vasopressin induces human mesangial cell growth via induction of vascular endothelial growth factor secretion.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Neuropeptides; 2011 Apr; 45(2):105-11. PubMed ID: 21196048
[TBL] [Abstract][Full Text] [Related]
11. Vasopressin regulates rat mesangial cell growth by inducing autocrine secretion of vascular endothelial growth factor.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
J Physiol Sci; 2011 Mar; 61(2):115-22. PubMed ID: 21229342
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological characterization of RWJ-676070, a dual vasopressin V(1A)/V(2) receptor antagonist.
Gunnet JW; Wines P; Xiang M; Rybczynski P; Andrade-Gordon P; de Garavilla L; Parry TJ; Cheung WM; Minor L; Demarest KT; Maryanoff BE; Damiano BP
Eur J Pharmacol; 2008 Aug; 590(1-3):333-42. PubMed ID: 18599033
[TBL] [Abstract][Full Text] [Related]
13. Effects of high glucose on AVP-induced hyperplasia, hypertrophy, and type IV collagen synthesis in cultured rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Endocr Res; 2012; 37(4):216-27. PubMed ID: 22594926
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic vasopressin V1b receptors: characterization in In-R1-G9 cells and localization in human pancreas.
Folny V; Raufaste D; Lukovic L; Pouzet B; Rochard P; Pascal M; Serradeil-Le Gal C
Am J Physiol Endocrinol Metab; 2003 Sep; 285(3):E566-76. PubMed ID: 12736162
[TBL] [Abstract][Full Text] [Related]
15. Vasopressin increases type IV collagen production through the induction of transforming growth factor-beta secretion in rat mesangial cells.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Pharmacol Res; 2008 Feb; 57(2):142-50. PubMed ID: 18299204
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of vasopressin V1A receptors and activation of mitogen-activated protein kinase in rat mesangial cells cultured under high-glucose conditions.
Tahara A; Tsukada J; Tomura Y; Yatsu T; Shibasaki M
Clin Exp Pharmacol Physiol; 2012 May; 39(5):438-46. PubMed ID: 22352691
[TBL] [Abstract][Full Text] [Related]
17. Biochemical and pharmacological properties of SR 49059, a new, potent, nonpeptide antagonist of rat and human vasopressin V1a receptors.
Serradeil-Le Gal C; Wagnon J; Garcia C; Lacour C; Guiraudou P; Christophe B; Villanova G; Nisato D; Maffrand JP; Le Fur G
J Clin Invest; 1993 Jul; 92(1):224-31. PubMed ID: 8392086
[TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo pharmacological characterisation of the potent and selective vasopressin V(1A) receptor antagonist 4-[4-(4-Chloro-phenyl)-5-[1,2,3]triazol-2-ylmethyl-4H-[1,2,4]triazol-3-yl]-piperidin-1-yl-(3,5-difluoro-phenyl) methanone (PF-00738245).
Russell R; Doyle R; Turner J; Attkins N; Ramsey S; Weibley L; Bateman L; Bictash M; Neal-Morgan S; Ivarsson M; Pullen N
Eur J Pharmacol; 2011 Nov; 670(2-3):347-55. PubMed ID: 21958878
[TBL] [Abstract][Full Text] [Related]
19. The mitogen-activated protein kinase Erk5 mediates human mesangial cell activation.
Dorado F; Velasco S; Esparís-Ogando A; Pericacho M; Pandiella A; Silva J; López-Novoa JM; Rodríguez-Barbero A
Nephrol Dial Transplant; 2008 Nov; 23(11):3403-11. PubMed ID: 18567890
[TBL] [Abstract][Full Text] [Related]
20. Pharmacologic characterization of the oxytocin receptor in human uterine smooth muscle cells.
Tahara A; Tsukada J; Tomura Y; Wada Ki; Kusayama T; Ishii N; Yatsu T; Uchida W; Tanaka A
Br J Pharmacol; 2000 Jan; 129(1):131-9. PubMed ID: 10694212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
